Carl Icahn Takes Stake in Bristol-Myers

The same day Bristol-Myers Squibb Co. shook up its board to satisfy one activist investor, the drugmaker was faced with another: Carl Icahn, whose interest is fueling speculation the company could soon be put on the auction block.

Source: WSJ.com: Health - February 22, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news